Burden of gastroesophageal reflux disease in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of disease study 2019

For effective preventive strategies against GORD (gastro-esophageal reflux disease), we assessed the GORD burden from 1990 to 2019. The burden of GORD between 1990 and 2019 was evaluated globally, regionally, and nationally. Using ASIR (age-standardized incidence), ASYLDs (age-standardized years liv...

Full description

Saved in:
Bibliographic Details
Published inBMC public health Vol. 23; no. 1; pp. 582 - 13
Main Authors Li, Na, Yang, Wan-Li, Cai, Mei-Hong, Chen, Xiang, Zhao, Ran, Li, Meng-Ting, Yan, Xia-Lin, Xue, Li-Wei, Hong, Liu, Tang, Ming-Yu
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 29.03.2023
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract For effective preventive strategies against GORD (gastro-esophageal reflux disease), we assessed the GORD burden from 1990 to 2019. The burden of GORD between 1990 and 2019 was evaluated globally, regionally, and nationally. Using ASIR (age-standardized incidence), ASYLDs (age-standardized years lived with disabilitys), we compared them to the GBD world population per 100,000. The estimates were based on 95% uncertainty intervals (UIs). The AAPC (average annual percent change) in incidence, YLDs, along with prevalence rates with associated 95% CIs were estimated. Data to estimate the burden of GORD are scarce till now. The global ASIR of GORD in 2019 was 3792.79 per 100,000, an increase AAPC of 0.112% from 1990. The prevalence of GORD increased with a AAPC of 0.096% to 9574.45 per 100,000. Global ASYLDs in 2019 was 73.63, an increase AAPC of 0.105% from 1990. The GORD burden varies greatly depending on the development level and geographical location. USA demonstrated the most obvious decreasing trend in burden of GORD, while Sweden had an increasing trend. That the increase in GORD YLDs was mediated primarily by the growth and aging of population, was revealed by decomposition analyses. There was an inverse relationship between SDI (socio-demographic index) and GORD-burden. Frontier analyses revealed significant scope of improvement in the status of development at all levels. GORD is a public health challenge, especially in Latin America. Some SDI quintiles had declining rates, while some countries experienced increased rates. Thus, resources should be allocated for preventative measures based on country-specific estimates.
AbstractList Introduction For effective preventive strategies against GORD (gastro-esophageal reflux disease), we assessed the GORD burden from 1990 to 2019. Methods The burden of GORD between 1990 and 2019 was evaluated globally, regionally, and nationally. Using ASIR (age-standardized incidence), ASYLDs (age-standardized years lived with disabilitys), we compared them to the GBD world population per 100,000. The estimates were based on 95% uncertainty intervals (UIs). The AAPC (average annual percent change) in incidence, YLDs, along with prevalence rates with associated 95% CIs were estimated. Results Data to estimate the burden of GORD are scarce till now. The global ASIR of GORD in 2019 was 3792.79 per 100,000, an increase AAPC of 0.112% from 1990. The prevalence of GORD increased with a AAPC of 0.096% to 9574.45 per 100,000. Global ASYLDs in 2019 was 73.63, an increase AAPC of 0.105% from 1990. The GORD burden varies greatly depending on the development level and geographical location. USA demonstrated the most obvious decreasing trend in burden of GORD, while Sweden had an increasing trend. That the increase in GORD YLDs was mediated primarily by the growth and aging of population, was revealed by decomposition analyses. There was an inverse relationship between SDI (socio-demographic index) and GORD-burden. Frontier analyses revealed significant scope of improvement in the status of development at all levels. Conclusion GORD is a public health challenge, especially in Latin America. Some SDI quintiles had declining rates, while some countries experienced increased rates. Thus, resources should be allocated for preventative measures based on country-specific estimates. Keywords: Gastro-esophageal reflux disease, Global burden disease, Age-standardized rate, Epidemiology
For effective preventive strategies against GORD (gastro-esophageal reflux disease), we assessed the GORD burden from 1990 to 2019.INTRODUCTIONFor effective preventive strategies against GORD (gastro-esophageal reflux disease), we assessed the GORD burden from 1990 to 2019.The burden of GORD between 1990 and 2019 was evaluated globally, regionally, and nationally. Using ASIR (age-standardized incidence), ASYLDs (age-standardized years lived with disabilitys), we compared them to the GBD world population per 100,000. The estimates were based on 95% uncertainty intervals (UIs). The AAPC (average annual percent change) in incidence, YLDs, along with prevalence rates with associated 95% CIs were estimated.METHODSThe burden of GORD between 1990 and 2019 was evaluated globally, regionally, and nationally. Using ASIR (age-standardized incidence), ASYLDs (age-standardized years lived with disabilitys), we compared them to the GBD world population per 100,000. The estimates were based on 95% uncertainty intervals (UIs). The AAPC (average annual percent change) in incidence, YLDs, along with prevalence rates with associated 95% CIs were estimated.Data to estimate the burden of GORD are scarce till now. The global ASIR of GORD in 2019 was 3792.79 per 100,000, an increase AAPC of 0.112% from 1990. The prevalence of GORD increased with a AAPC of 0.096% to 9574.45 per 100,000. Global ASYLDs in 2019 was 73.63, an increase AAPC of 0.105% from 1990. The GORD burden varies greatly depending on the development level and geographical location. USA demonstrated the most obvious decreasing trend in burden of GORD, while Sweden had an increasing trend. That the increase in GORD YLDs was mediated primarily by the growth and aging of population, was revealed by decomposition analyses. There was an inverse relationship between SDI (socio-demographic index) and GORD-burden. Frontier analyses revealed significant scope of improvement in the status of development at all levels.RESULTSData to estimate the burden of GORD are scarce till now. The global ASIR of GORD in 2019 was 3792.79 per 100,000, an increase AAPC of 0.112% from 1990. The prevalence of GORD increased with a AAPC of 0.096% to 9574.45 per 100,000. Global ASYLDs in 2019 was 73.63, an increase AAPC of 0.105% from 1990. The GORD burden varies greatly depending on the development level and geographical location. USA demonstrated the most obvious decreasing trend in burden of GORD, while Sweden had an increasing trend. That the increase in GORD YLDs was mediated primarily by the growth and aging of population, was revealed by decomposition analyses. There was an inverse relationship between SDI (socio-demographic index) and GORD-burden. Frontier analyses revealed significant scope of improvement in the status of development at all levels.GORD is a public health challenge, especially in Latin America. Some SDI quintiles had declining rates, while some countries experienced increased rates. Thus, resources should be allocated for preventative measures based on country-specific estimates.CONCLUSIONGORD is a public health challenge, especially in Latin America. Some SDI quintiles had declining rates, while some countries experienced increased rates. Thus, resources should be allocated for preventative measures based on country-specific estimates.
For effective preventive strategies against GORD (gastro-esophageal reflux disease), we assessed the GORD burden from 1990 to 2019. The burden of GORD between 1990 and 2019 was evaluated globally, regionally, and nationally. Using ASIR (age-standardized incidence), ASYLDs (age-standardized years lived with disabilitys), we compared them to the GBD world population per 100,000. The estimates were based on 95% uncertainty intervals (UIs). The AAPC (average annual percent change) in incidence, YLDs, along with prevalence rates with associated 95% CIs were estimated. Data to estimate the burden of GORD are scarce till now. The global ASIR of GORD in 2019 was 3792.79 per 100,000, an increase AAPC of 0.112% from 1990. The prevalence of GORD increased with a AAPC of 0.096% to 9574.45 per 100,000. Global ASYLDs in 2019 was 73.63, an increase AAPC of 0.105% from 1990. The GORD burden varies greatly depending on the development level and geographical location. USA demonstrated the most obvious decreasing trend in burden of GORD, while Sweden had an increasing trend. That the increase in GORD YLDs was mediated primarily by the growth and aging of population, was revealed by decomposition analyses. There was an inverse relationship between SDI (socio-demographic index) and GORD-burden. Frontier analyses revealed significant scope of improvement in the status of development at all levels. GORD is a public health challenge, especially in Latin America. Some SDI quintiles had declining rates, while some countries experienced increased rates. Thus, resources should be allocated for preventative measures based on country-specific estimates.
IntroductionFor effective preventive strategies against GORD (gastro-esophageal reflux disease), we assessed the GORD burden from 1990 to 2019.MethodsThe burden of GORD between 1990 and 2019 was evaluated globally, regionally, and nationally. Using ASIR (age-standardized incidence), ASYLDs (age-standardized years lived with disabilitys), we compared them to the GBD world population per 100,000. The estimates were based on 95% uncertainty intervals (UIs). The AAPC (average annual percent change) in incidence, YLDs, along with prevalence rates with associated 95% CIs were estimated.ResultsData to estimate the burden of GORD are scarce till now. The global ASIR of GORD in 2019 was 3792.79 per 100,000, an increase AAPC of 0.112% from 1990. The prevalence of GORD increased with a AAPC of 0.096% to 9574.45 per 100,000. Global ASYLDs in 2019 was 73.63, an increase AAPC of 0.105% from 1990. The GORD burden varies greatly depending on the development level and geographical location. USA demonstrated the most obvious decreasing trend in burden of GORD, while Sweden had an increasing trend. That the increase in GORD YLDs was mediated primarily by the growth and aging of population, was revealed by decomposition analyses. There was an inverse relationship between SDI (socio-demographic index) and GORD-burden. Frontier analyses revealed significant scope of improvement in the status of development at all levels.ConclusionGORD is a public health challenge, especially in Latin America. Some SDI quintiles had declining rates, while some countries experienced increased rates. Thus, resources should be allocated for preventative measures based on country-specific estimates.
Abstract Introduction For effective preventive strategies against GORD (gastro-esophageal reflux disease), we assessed the GORD burden from 1990 to 2019. Methods The burden of GORD between 1990 and 2019 was evaluated globally, regionally, and nationally. Using ASIR (age-standardized incidence), ASYLDs (age-standardized years lived with disabilitys), we compared them to the GBD world population per 100,000. The estimates were based on 95% uncertainty intervals (UIs). The AAPC (average annual percent change) in incidence, YLDs, along with prevalence rates with associated 95% CIs were estimated. Results Data to estimate the burden of GORD are scarce till now. The global ASIR of GORD in 2019 was 3792.79 per 100,000, an increase AAPC of 0.112% from 1990. The prevalence of GORD increased with a AAPC of 0.096% to 9574.45 per 100,000. Global ASYLDs in 2019 was 73.63, an increase AAPC of 0.105% from 1990. The GORD burden varies greatly depending on the development level and geographical location. USA demonstrated the most obvious decreasing trend in burden of GORD, while Sweden had an increasing trend. That the increase in GORD YLDs was mediated primarily by the growth and aging of population, was revealed by decomposition analyses. There was an inverse relationship between SDI (socio-demographic index) and GORD-burden. Frontier analyses revealed significant scope of improvement in the status of development at all levels. Conclusion GORD is a public health challenge, especially in Latin America. Some SDI quintiles had declining rates, while some countries experienced increased rates. Thus, resources should be allocated for preventative measures based on country-specific estimates.
For effective preventive strategies against GORD (gastro-esophageal reflux disease), we assessed the GORD burden from 1990 to 2019. The burden of GORD between 1990 and 2019 was evaluated globally, regionally, and nationally. Using ASIR (age-standardized incidence), ASYLDs (age-standardized years lived with disabilitys), we compared them to the GBD world population per 100,000. The estimates were based on 95% uncertainty intervals (UIs). The AAPC (average annual percent change) in incidence, YLDs, along with prevalence rates with associated 95% CIs were estimated. Data to estimate the burden of GORD are scarce till now. The global ASIR of GORD in 2019 was 3792.79 per 100,000, an increase AAPC of 0.112% from 1990. The prevalence of GORD increased with a AAPC of 0.096% to 9574.45 per 100,000. Global ASYLDs in 2019 was 73.63, an increase AAPC of 0.105% from 1990. The GORD burden varies greatly depending on the development level and geographical location. USA demonstrated the most obvious decreasing trend in burden of GORD, while Sweden had an increasing trend. That the increase in GORD YLDs was mediated primarily by the growth and aging of population, was revealed by decomposition analyses. There was an inverse relationship between SDI (socio-demographic index) and GORD-burden. Frontier analyses revealed significant scope of improvement in the status of development at all levels. GORD is a public health challenge, especially in Latin America. Some SDI quintiles had declining rates, while some countries experienced increased rates. Thus, resources should be allocated for preventative measures based on country-specific estimates.
ArticleNumber 582
Audience Academic
Author Yang, Wan-Li
Xue, Li-Wei
Zhao, Ran
Cai, Mei-Hong
Yan, Xia-Lin
Li, Meng-Ting
Li, Na
Tang, Ming-Yu
Hong, Liu
Chen, Xiang
Author_xml – sequence: 1
  givenname: Na
  surname: Li
  fullname: Li, Na
– sequence: 2
  givenname: Wan-Li
  surname: Yang
  fullname: Yang, Wan-Li
– sequence: 3
  givenname: Mei-Hong
  surname: Cai
  fullname: Cai, Mei-Hong
– sequence: 4
  givenname: Xiang
  surname: Chen
  fullname: Chen, Xiang
– sequence: 5
  givenname: Ran
  surname: Zhao
  fullname: Zhao, Ran
– sequence: 6
  givenname: Meng-Ting
  surname: Li
  fullname: Li, Meng-Ting
– sequence: 7
  givenname: Xia-Lin
  surname: Yan
  fullname: Yan, Xia-Lin
– sequence: 8
  givenname: Li-Wei
  surname: Xue
  fullname: Xue, Li-Wei
– sequence: 9
  givenname: Liu
  surname: Hong
  fullname: Hong, Liu
– sequence: 10
  givenname: Ming-Yu
  surname: Tang
  fullname: Tang, Ming-Yu
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36978027$$D View this record in MEDLINE/PubMed
BookMark eNp9ks1u1DAUhSNURH_gBVggS2xYkGI7TuywqUoFpVIlNrC2HPt6xqNMXOwEMV3xDux4PJ6Em05Lf4RQFkluzv1OjnX2i50hDlAUzxk9ZEw1bzLjSrUl5VXJai55efmo2GNCspKLWu3ced4t9nNeUcqkqvmTYrdqWqkol3vFr3dTcjCQ6MnC5DFFyPFiaRZgepLA99N34kIGk4GEgXAqiI3TMKYAmZjBkRFSCmOc318T1rb094-fnLL2LTEkb_IIazMGi1LTb3LIxMdExiWQ0z52aHHrfuOSx8ltyIx4Wjz2ps_w7Pp-UHz58P7zycfy_NPp2cnxeWnrRowlOKDSUO-ZAtqqqlaisR7DNYBjZY2TDZeCNR3r6roBL1ktfcfqzjUOVdVBcbblumhW-iKFtUkbHU3QV4OYFtokDNGD5s7Mm8Zb3glbi05W1Eo0Fa2tVCuRdbRlXUzdGpwFPCrT34Pe_zKEpV7Eb5pRWlf4n0h4dU1I8esEedTrkC30vRkgTllz2fKaci4qlL58IF3FKeFJo0rRConYklvVwmCCMPiIxnaG6mMpKiFaXs22h_9Q4eVgHSz2zgec31t4cTfp34g31UKB2gpsijljl7QNI5YhzsFDj4n13GK9bbHGFuurFutLXOUPVm_o_1n6A5BF884
CitedBy_id crossref_primary_10_1088_2057_1976_ad5a14
crossref_primary_10_1016_j_clnesp_2024_11_028
crossref_primary_10_31146_1682_8658_ecg_218_10_77_87
crossref_primary_10_32388_LJ6FPN
crossref_primary_10_7759_cureus_60814
crossref_primary_10_1007_s10620_024_08765_3
crossref_primary_10_7704_kjhugr_2024_0020
crossref_primary_10_1097_MOG_0000000000001082
crossref_primary_10_1111_nmo_14969
crossref_primary_10_1111_apt_18458
crossref_primary_10_7759_cureus_50840
crossref_primary_10_3390_diagnostics13243602
crossref_primary_10_3390_medicina59071270
crossref_primary_10_21518_ms2024_039
crossref_primary_10_3390_nu16162779
crossref_primary_10_1186_s12903_025_05516_2
crossref_primary_10_1097_01_JAA_0001005620_54669_f4
crossref_primary_10_2147_JMDH_S485781
crossref_primary_10_3390_s23218858
crossref_primary_10_1021_acsami_3c13825
crossref_primary_10_3390_healthcare11192637
crossref_primary_10_4253_wjge_v17_i1_100219
crossref_primary_10_3390_ijerph21121696
crossref_primary_10_1016_j_resinv_2024_08_007
crossref_primary_10_1371_journal_pone_0306223
crossref_primary_10_3389_fimmu_2025_1420132
crossref_primary_10_1111_ppe_13156
crossref_primary_10_3389_fmed_2024_1346888
crossref_primary_10_3748_wjg_v31_i4_101933
crossref_primary_10_1007_s00394_024_03491_y
crossref_primary_10_1097_MD_0000000000039248
crossref_primary_10_12677_acm_2025_152395
crossref_primary_10_1155_2024_9990554
crossref_primary_10_21518_ms2024_546
crossref_primary_10_1007_s10620_024_08290_3
Cites_doi 10.1016/j.ejim.2015.05.005
10.1001/jamaoncol.2019.2996
10.1002/alr.22259
10.1016/S0140-6736(20)30925-9
10.3109/00365520903428606
10.1016/S0140-6736(06)68932-0
10.1038/s41572-021-00287-w
10.2174/1874306401206010121
10.1016/j.bpg.2017.09.004
10.1136/gutjnl-2016-313589
10.1016/j.bpg.2013.06.008
10.1136/gutjnl-2012-304269
10.3748/wjg.v19.i39.6523
10.1097/MD.0000000000004089
10.1016/j.kint.2018.04.011
10.1053/j.gastro.2017.01.031
10.1016/j.cgh.2022.06.003
10.1038/s41598-020-62795-1
10.1001/jama.2020.21360
10.1111/nmo.14022
10.1016/S0140-6736(20)30752-2
10.1016/S2468-1253(19)30408-X
ContentType Journal Article
Copyright 2023. The Author(s).
COPYRIGHT 2023 BioMed Central Ltd.
2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2023
Copyright_xml – notice: 2023. The Author(s).
– notice: COPYRIGHT 2023 BioMed Central Ltd.
– notice: 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2023
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7T2
7X7
7XB
88E
8C1
8FE
8FG
8FI
8FJ
8FK
ABJCF
ABUWG
AEUYN
AFKRA
AN0
ATCPS
AZQEC
BENPR
BGLVJ
BHPHI
C1K
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
L6V
M0S
M1P
M7S
PATMY
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PTHSS
PYCSY
7X8
5PM
DOA
DOI 10.1186/s12889-023-15272-z
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health and Safety Science Abstracts (Full archive)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Public Health Database
ProQuest SciTech Collection
ProQuest Technology Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Collection
ProQuest Central (Alumni)
ProQuest One Sustainability (subscription)
ProQuest Central UK/Ireland
British Nursing Database
Agricultural & Environmental Science Collection
ProQuest Central Essentials
ProQuest Central
Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Engineering Collection
Health & Medical Collection (Alumni)
Medical Database
Engineering Database (ProQuest)
Environmental Science Database (ProQuest)
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Engineering Collection
Environmental Science Collection
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
Technology Collection
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
ProQuest Engineering Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Agricultural & Environmental Science Collection
Health & Safety Science Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Engineering Collection
Engineering Database
ProQuest Public Health
ProQuest One Academic Eastern Edition
British Nursing Index with Full Text
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Environmental Science Collection
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Materials Science & Engineering Collection
Environmental Science Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE
Publicly Available Content Database


Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals (DOAJ) (Open Access)
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
EISSN 1471-2458
EndPage 13
ExternalDocumentID oai_doaj_org_article_2dafb15afc2b4c54b730c798349c3897
PMC10053627
A743449237
36978027
10_1186_s12889_023_15272_z
Genre Journal Article
GeographicLocations China
Southeast Asia
Asia
United States--US
Brazil
East Asia
Paraguay
North America
Central Europe
Oceania
Latin America
North Korea
GeographicLocations_xml – name: China
– name: Asia
– name: North Korea
– name: East Asia
– name: Latin America
– name: Southeast Asia
– name: Paraguay
– name: Central Europe
– name: Oceania
– name: North America
– name: United States--US
– name: Brazil
GroupedDBID ---
0R~
23N
2WC
2XV
44B
53G
5VS
6J9
6PF
7X7
7XC
88E
8C1
8FE
8FG
8FH
8FI
8FJ
A8Z
AAFWJ
AAJSJ
AASML
AAWTL
AAYXX
ABDBF
ABJCF
ABUWG
ACGFO
ACGFS
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
ADUKV
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AN0
AOIJS
ATCPS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BGLVJ
BHPHI
BMC
BNQBC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
L6V
M1P
M48
M7S
M~E
O5R
O5S
OK1
OVT
P2P
PATMY
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
PTHSS
PYCSY
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
U2A
UKHRP
W2D
WOQ
WOW
XSB
-A0
3V.
ACRMQ
ADINQ
C24
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
7T2
7XB
8FK
AZQEC
C1K
DWQXO
GNUQQ
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c564t-ede07a0ff18e09835846cf0276e7a08cad7627416b1b556ef7157fb15bd6d2763
IEDL.DBID M48
ISSN 1471-2458
IngestDate Wed Aug 27 01:32:37 EDT 2025
Thu Aug 21 18:37:49 EDT 2025
Fri Jul 11 02:39:35 EDT 2025
Fri Jul 25 10:43:19 EDT 2025
Tue Jun 17 21:31:59 EDT 2025
Tue Jun 10 20:23:02 EDT 2025
Wed Feb 19 02:24:30 EST 2025
Thu Apr 24 23:11:51 EDT 2025
Tue Jul 01 00:56:49 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Age-standardized rate
Gastro-esophageal reflux disease
Epidemiology
Global burden disease
Language English
License 2023. The Author(s).
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c564t-ede07a0ff18e09835846cf0276e7a08cad7627416b1b556ef7157fb15bd6d2763
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12889-023-15272-z
PMID 36978027
PQID 2803005186
PQPubID 44782
PageCount 13
ParticipantIDs doaj_primary_oai_doaj_org_article_2dafb15afc2b4c54b730c798349c3897
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10053627
proquest_miscellaneous_2792502243
proquest_journals_2803005186
gale_infotracmisc_A743449237
gale_infotracacademiconefile_A743449237
pubmed_primary_36978027
crossref_citationtrail_10_1186_s12889_023_15272_z
crossref_primary_10_1186_s12889_023_15272_z
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-03-29
PublicationDateYYYYMMDD 2023-03-29
PublicationDate_xml – month: 03
  year: 2023
  text: 2023-03-29
  day: 29
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC public health
PublicationTitleAlternate BMC Public Health
PublicationYear 2023
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References A Ruigómez (15272_CR21) 2010; 45
LH Eusebi (15272_CR4) 2018; 67
Collaborators GBDG-oRD (15272_CR15) 2020; 5
J Maret-Ouda (15272_CR7) 2020; 324
HB El-Serag (15272_CR13) 2014; 63
Collaborators GBDRF (15272_CR17) 2020; 396
HN Khan (15272_CR10) 2018; 30
A Ustaoglu (15272_CR2) 2020; 32
ZH You (15272_CR8) 2015; 26
CH Chen (15272_CR11) 2016; 95
H Saber (15272_CR5) 2012; 6
J Ronkainen (15272_CR12) 2013; 27
GBD Diseases (15272_CR19) 2020; 396
R Fass (15272_CR1) 2021; 7
Y Xie (15272_CR16) 2018; 94
VR Muthusamy (15272_CR22) 2022; 20
JS Nirwan (15272_CR14) 2020; 10
A Altomare (15272_CR6) 2013; 19
DE Freedberg (15272_CR24) 2017; 152
C Fitzmaurice (15272_CR18) 2019; 5
DA Katzka (15272_CR23) 2020; 371
P Moayyedi (15272_CR3) 2006; 367
SY Kim (15272_CR9) 2019; 9
E Ness-Jensen (15272_CR20) 2017; 31
References_xml – volume: 26
  start-page: 534
  issue: 7
  year: 2015
  ident: 15272_CR8
  publication-title: Eur J Intern Med
  doi: 10.1016/j.ejim.2015.05.005
– volume: 5
  start-page: 1749
  issue: 12
  year: 2019
  ident: 15272_CR18
  publication-title: JAMA Oncol
  doi: 10.1001/jamaoncol.2019.2996
– volume: 9
  start-page: 357
  issue: 4
  year: 2019
  ident: 15272_CR9
  publication-title: Int Forum Allergy Rhinol
  doi: 10.1002/alr.22259
– volume: 396
  start-page: 1204
  issue: 10258
  year: 2020
  ident: 15272_CR19
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)30925-9
– volume: 45
  start-page: 139
  issue: 2
  year: 2010
  ident: 15272_CR21
  publication-title: Scand J Gastroenterol
  doi: 10.3109/00365520903428606
– volume: 367
  start-page: 2086
  issue: 9528
  year: 2006
  ident: 15272_CR3
  publication-title: Lancet
  doi: 10.1016/S0140-6736(06)68932-0
– volume: 30
  start-page: 64
  issue: 1
  year: 2018
  ident: 15272_CR10
  publication-title: J Ayub Med Coll, Abbottabad: JAMC
– volume: 7
  start-page: 55
  issue: 1
  year: 2021
  ident: 15272_CR1
  publication-title: Nat Rev Dis Primers
  doi: 10.1038/s41572-021-00287-w
– volume: 6
  start-page: 121
  year: 2012
  ident: 15272_CR5
  publication-title: Open Respir Med J
  doi: 10.2174/1874306401206010121
– volume: 31
  start-page: 501
  issue: 5
  year: 2017
  ident: 15272_CR20
  publication-title: Best Pract Res Clin Gastroenterol
  doi: 10.1016/j.bpg.2017.09.004
– volume: 67
  start-page: 430
  issue: 3
  year: 2018
  ident: 15272_CR4
  publication-title: Gut
  doi: 10.1136/gutjnl-2016-313589
– volume: 27
  start-page: 325
  issue: 3
  year: 2013
  ident: 15272_CR12
  publication-title: Best Pract Res Clin Gastroenterol
  doi: 10.1016/j.bpg.2013.06.008
– volume: 63
  start-page: 871
  issue: 6
  year: 2014
  ident: 15272_CR13
  publication-title: Gut
  doi: 10.1136/gutjnl-2012-304269
– volume: 19
  start-page: 6523
  issue: 39
  year: 2013
  ident: 15272_CR6
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v19.i39.6523
– volume: 95
  start-page: e4089
  issue: 27
  year: 2016
  ident: 15272_CR11
  publication-title: Medicine (Baltimore)
  doi: 10.1097/MD.0000000000004089
– volume: 94
  start-page: 567
  issue: 3
  year: 2018
  ident: 15272_CR16
  publication-title: Kidney Int
  doi: 10.1016/j.kint.2018.04.011
– volume: 152
  start-page: 706
  issue: 4
  year: 2017
  ident: 15272_CR24
  publication-title: Gastroenterol
  doi: 10.1053/j.gastro.2017.01.031
– volume: 20
  start-page: 2696
  issue: 12
  year: 2022
  ident: 15272_CR22
  publication-title: Clin Gastroenterol Hepatol
  doi: 10.1016/j.cgh.2022.06.003
– volume: 10
  start-page: 5814
  issue: 1
  year: 2020
  ident: 15272_CR14
  publication-title: Sci Rep
  doi: 10.1038/s41598-020-62795-1
– volume: 324
  start-page: 2536
  issue: 24
  year: 2020
  ident: 15272_CR7
  publication-title: JAMA
  doi: 10.1001/jama.2020.21360
– volume: 371
  start-page: m3786
  year: 2020
  ident: 15272_CR23
  publication-title: BMJ (Clinical Research ed)
– volume: 32
  start-page: e14022
  issue: 12
  year: 2020
  ident: 15272_CR2
  publication-title: Neurogastroenterol Motil J Eur Gastrointest Motil Soc
  doi: 10.1111/nmo.14022
– volume: 396
  start-page: 1223
  issue: 10258
  year: 2020
  ident: 15272_CR17
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)30752-2
– volume: 5
  start-page: 561
  issue: 6
  year: 2020
  ident: 15272_CR15
  publication-title: Lancet Gastroenterol Hepatol
  doi: 10.1016/S2468-1253(19)30408-X
SSID ssj0017852
Score 2.545568
Snippet For effective preventive strategies against GORD (gastro-esophageal reflux disease), we assessed the GORD burden from 1990 to 2019. The burden of GORD between...
Introduction For effective preventive strategies against GORD (gastro-esophageal reflux disease), we assessed the GORD burden from 1990 to 2019. Methods The...
For effective preventive strategies against GORD (gastro-esophageal reflux disease), we assessed the GORD burden from 1990 to 2019. The burden of GORD between...
IntroductionFor effective preventive strategies against GORD (gastro-esophageal reflux disease), we assessed the GORD burden from 1990 to 2019.MethodsThe...
For effective preventive strategies against GORD (gastro-esophageal reflux disease), we assessed the GORD burden from 1990 to 2019.INTRODUCTIONFor effective...
Abstract Introduction For effective preventive strategies against GORD (gastro-esophageal reflux disease), we assessed the GORD burden from 1990 to 2019....
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 582
SubjectTerms Age
Age factors in disease
Age-standardized rate
Analysis
Care and treatment
Diagnosis
Disease
Epidemiology
Esophagus
Estimates
Gastro-esophageal reflux disease
Gastroesophageal reflux
Gastroesophageal Reflux - epidemiology
Geographical distribution
Geographical locations
Global burden disease
Global Burden of Disease
Global Health
High income
Humans
Incidence
Population
Prevalence
Public health
Quality-Adjusted Life Years
Regions
Risk factors
Trends
World population
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NaxUxEA_SkyDit6tVRhA86NL9yNd6q2Ipgp4s9BaSbKKFsk_69oH05P_gzT_Pv8SZZPf1LYJevCaTbJKZzEw2md8w9pw7bdFshzLS_T9dFJVWKVXiedl12nstNQUKf_goj0_4-1NxupPqi96EZXjgvHAHTW-jq4WNvnHcC-5QJL3qdMs7j8Y2xZGjzZsPU9P9gdKimUNktDxYoxamp0FNW1Ia16a8XJihhNb_p07eMUrLB5M7FujoFrs5uY5wmId8m10Lwx12I_93gxxOdJf9zHEJsIrw2a7Hi1WgPAWoNLAljuJ88w2mOxk4G6CpOKRsEXRgBjv0MBJSIwGHhPUrqNGI_Pr-A6139xosXKE-I2nGMgH0eQF9SMi5A-Dq6_NXEn4tUBf32MnRu09vj8sp_0LpheRjGfpQKVvFWOtQ4YqTr-KRp0oGLNbe9ipl7pGudkLIEFUtFDHL9bJHqvY-2xtWQ3jIIPai66LFfmzHK-t064WTMapWxL7VfcHqmR3GT-DklCPj3KRDipYms9AgC01iobks2Mttm68ZmuOv1G-Iy1tKgtVOBShsZhI28y9hK9gLkhFDmx-H5-0Uw4CTJBgtc4j-GCfIO6TcX1DipvXL6lnKzKQ01oYShZGS1LJgz7bV1JIewg1htUEa1aHTin5XW7AHWSi3U2olwUk12LleiOtizsua4exLghSvSRkjMx_9j1V6zK43tNUqyhK4z_bGi014gq7b6J6mXfobm75AOw
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Technology Collection
  dbid: 8FG
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LaxUxFA5aN4KIb6dWiSC40KHzymPcSBWvRdCVhe5CkklqoczUO3OhdOV_cOfP85d4TiYzt4PQ7eQkk3BOzjl5fR8hryojNYRtl3o8_8eDolQLIVJYL5taWiu5xIfCX7_xw6PqyzE7jhtufbxWOfnE4KibzuIe-T6yKKEFSf7-_GeKrFF4uhopNG6SWzlEGrzSJVef51MEIVkxPZSRfL8HX4wXhIoyRTLXIr1cBKOA2f-_Z74SmpbXJq_EodU9cjcmkPRg1Ph9csO1D8idcfeNjo-KHpI_4-sE2nl6ovth3TlkKwDXATWhF2ebCxpPZuhpS4usooEzApfNVLcNHRCvEeFDXP-W5hBK_v76DTG8fkc13WI_g-iIaEIh86WQSdKRQYBu_z79JaDYUmziETlaffr-8TCNLAypZbwaUte4TOjM-1y6rIaEDTIWC5oV3MFnaXUjAn8PN7lhjDsvcia8yZlpeANS5WOy03ate0qob1hdew3t6LrKtJGlZYZ7L0rmm1I2CckndSgbIcqRKeNMhaWK5GpUoQIVqqBCdZmQN3Od8xGg41rpD6jlWRLBtcOHbn2i4lxVRaOx_9rbwlSWVQa8oBUw9Kq2kN-JhLxGG1HoAqB7VseXDDBIBNNSB5CVVQh8B5J7C0mYunZZPFmZiq6jV1tDT8jLuRhr4nW41nUbkBE1pK6QfZUJeTIa5TykkiOoVAGNy4W5Lsa8LGlPfwRg8RxdMihz9_p-PSO3C5xEGbIA7pGdYb1xzyE1G8yLMP_-Ac5vN4U
  priority: 102
  providerName: ProQuest
Title Burden of gastroesophageal reflux disease in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of disease study 2019
URI https://www.ncbi.nlm.nih.gov/pubmed/36978027
https://www.proquest.com/docview/2803005186
https://www.proquest.com/docview/2792502243
https://pubmed.ncbi.nlm.nih.gov/PMC10053627
https://doaj.org/article/2dafb15afc2b4c54b730c798349c3897
Volume 23
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1baxQxFA69vAgi3l2tSwTBBx2dS24jiHRL1yK0SHGh-BKSTFILy6zuBWp_iT_XczIzux0sfcnD5CSTzMk5OZkk30fIa2aVgWnbJwH3_3GjKDFSygTWy7ZUzimh8KLw8Yk4mrCvZ_xsi3R0R-0HXNy4tEM-qcl8-v7y95_PYPCfosEr8WEBPhYP_uRFgiSteXK1TXZhZpLIaHDMNrsKUkUGngwccpIzrrpLNDfW0ZuoIp7__1772rTVP1J5bY4a3yf32uCS7jej4QHZ8vVDcrf5M0ebC0ePyN_m5gKdBXpuFsv5zCOTAbgVKAmtmK4uabtrQy9qmqeMRj4JXFJTU1d0iViOCC3iF-9oBtMMmEBWfqSGblChQbDBOqEQE1OIMWnDLUA37-7eEfFtKVbxmEzGh98PjpKWnyFxXLBl4iufSpOGkCmflhDKQSzjQOdSeHisnKlkZPYRNrOcCx9kxmWwGbeVqECqeEJ26lntnxEaKl6WwUA9pmSpsapw3IoQZMFDVahqQLJOGdq14OXIoTHVcRGjhG4UqEGBOipQXw3I23WZXw10x63SI9TxWhJht-OD2fxct1as88pg-01wuWWOMwv-0UnoOisdRH5yQN7gCNE4XKF5zrR3HKCTCLOl9yFeYwiJB5J7PUkwatfP7saY7mxCI5EYOlElBuTVOhtL4kG52s9WICNLCGohLisG5GkzJNddKgTCTeVQueoN1l6f-zn1xc8IOZ6hswZlPr-92S_InRxNKEV-wD2ys5yv_EsI2pZ2SLblmYRUHWSYjr8Mye7o8OTb6TD-BhlGS4X0dPTjHwXAQRc
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3LbtUwELVKWYCEEG9uKWAkEAuImpcfQUKoPC639LFqpe5c27FLpSpp70NAV_wDOz6Cj-JLmHGSexshdddtMnZszXhmHHvOIeR5bqSGsO0ij-f_eFAUaSFEBPtlU0hrJZdYKLy9w0d7-Zd9tr9E_nS1MHitsvOJwVGXtcV_5GvIooQWJPm7k9MIWaPwdLWj0GjMYtP9-AZbtsnbjY-g3xdpOvy0-2EUtawCkWU8n0audLHQsfeJdHEBCQhEYAsjFdzBY2l1KQIfDTeJYYw7LxImvEmYKXkJUhn0e4VczTOI5FiZPvw8P7UQkqVdYY7kaxPw_XghKc0iJI9No7Ne8AscAf9HgnOhsH9N81zcG94iN9uEla43FnabLLnqDrnR_O2jTRHTXfK7qYagtaeHejId1w7ZEcBVQUsYxfHsO21PguhRRdM4p4GjArfpVFclnSI-JMKVuMlrmkDo-vvzF-QMxRuq6QJrGkQbBBUKmTaFzJU2jAV08fXuKwE1l2IX98jepejnPlmu6so9JNSXrCi8hn50kcfayMwyw70XGfNlJssBSTp1KNtCoiMzx7EKWyPJVaNCBSpUQYXqbEBezducNIAgF0q_Ry3PJRHMOzyox4eq9Q0qLTWOX3ubmtyy3IDXtQKmnhcW8kkxIC_RRhS6HBie1W3lBEwSwbvUOmSBOQLtgeRqTxJche2_7qxMta5qohYLa0CezV9jS7x-V7l6BjKigFQZsr1sQB40RjmfUsYRxCqFzmXPXHtz7r-pjr4GIPMEQwAoc-XicT0l10a721tqa2Nn8xG5nuKCCrcAV8nydDxzjyEtnJonYS1ScnDZi_8fsCdz5w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Burden+of+gastroesophageal+reflux+disease+in+204+countries+and+territories%2C+1990-2019%3A+a+systematic+analysis+for+the+Global+Burden+of+disease+study+2019&rft.jtitle=BMC+public+health&rft.au=Li%2C+Na&rft.au=Yang%2C+Wan-Li&rft.au=Cai%2C+Mei-Hong&rft.au=Chen%2C+Xiang&rft.date=2023-03-29&rft.pub=BioMed+Central+Ltd&rft.issn=1471-2458&rft.eissn=1471-2458&rft.volume=23&rft.issue=1&rft_id=info:doi/10.1186%2Fs12889-023-15272-z&rft.externalDocID=A743449237
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2458&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2458&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2458&client=summon